Translocation (14;16)(q32;q23) (MAF/IGH) FISH
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000595507.1
IMMUNOLOGYINHERITED DISEASECANCER ... View more
Last updated in GTR: 2021-09-08
Last annual review date for the lab: 2023-09-15 LinkOut
At a Glance
Prognostic
Multiple myeloma
Genes (2): Help
IGH (14q32.33), MAF (16q23.2)
Cytogenetics - FISH-interphase: Fluorescence in situ hybridization (FISH)
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
Duzen Laboratories
View lab's website
Test Order Code: Help
3641
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 2
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
FISH-interphase
Fluorescence in situ hybridization (FISH)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Prognostic
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Expected to be >99% if the cancer cell clone blast percentage/ cancer-associated mutation rate is greater than 5%
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.